lisuride sold brand name dopergin among others monoaminergic medication ergoline class used treatment parkinsons disease migraine high prolactin taken side effects lisuride include nausea vomiting dizziness headache fatigue drowsiness insomnia sleep gastrointestinal disturbances abdominal pain diarrhea nasal congestion runny nose hypotension hallucinations confusion particularly higher doses rarely serious side effects cardiac pulmonary fibrosis reported longterm use extremely lisuride acts mixed agonist antagonist dopamine serotonin adrenergic activation specific dopamine receptors thought responsible effectiveness treatment parkinsons disease ability suppress prolactin interactions serotonin receptors thought principally involved effectiveness lisuride used lower prolactin low doses prevent migraine use lisuride initial antiparkinsonian medication parkinsons disease advocated delaying need levodopa lisuride becomes insufficient controlling parkinsonian citations needed evidence insufficient support lisuride treatment advanced parkinsons disease alternative levodopa side effects lisuride include nausea lowered blood pressure among lisuride ligand dopamine serotonin adrenergic receptors well histamine subnanomolar affinity dopamine receptors serotonin receptors receptors lownanomolar affinity dopamine receptors serotonin receptors receptors histamine lisuride partial agonist receptors full nearfull agonist receptors silent antagonist receptor due highly nonselective pharmacological activity lisuride described dirty effectiveness lisuride parkinsons disease hyperprolactinemia thought mostly due activation dopamine lisuride similar receptor binding profile wellknown chemically similar ergoline lysergic acid diethylamide lsd nndiethyllysergamide acts partial agonist serotonin receptor lacks psychedelic effects research suggests lack psychedelic effects lisuride arises biased agonism receptor stimulation protomer within receptor complex evokes psychedelic effects effects occur sole stimulation monomeric receptors accordingly different g proteins lisuride behaves agonist receptor monomer since competitively antagonizes effects lsd may regarded protomer antagonist gpcr oligomers discrete entities usually possess properties distinct parent monomeric receptors lisuride dosedependently suppresses prolactin levels due dopaminergic antagonist receptor lisuride risk cardiac valvulopathy contrast related ergolines like pergolide minute amounts lisuride suppress firing dorsal raphe serotonergic neurons presumably due agonist activity receptors noradrenergic neurons locus coeruleus accelerated drug somewhat higher doses consistent receptor antagonist activity pars compacta dopamine neurons demonstrated variable response absorption lisuride gastrointestinal tract oral administration absolute bioavailability lisuride due high firstpass plasma protein binding lisuride peak levels lisuride occur minutes ingestion high variability elimination halflife lisuride approximately shorter dopamine lisuride known lisuride described free base hydrogen maleate bromination lisuride gives bromerguride reversed pharmacodynamic profile compared lisuride synthesized zikán semonský research institute pharmacy biochemistry prague later spofa antimigraine agent analogous methysergide described marketed early lisuride inntooltip international nonproprietary name lysuride bantooltip british approved lisuride sold brand names including arolac cuvalit dopagon dopergin dopergine eunal lisenil lizenil lysenyl proclacam prolacam lisuride previously widely available throughout appears marketed egypt france italy kuwait lebanon mexico new zealand lisuride currently available united states drug commercial success comparison dopamine receptor agonistscitation needed preliminary clinical research suggests transdermal administration lisuride may useful treatment parkinsons lisuride poor bioavailability taken orally short halflife continuous transdermal administration offers significant advantages could make compound much consistent therapeutic lisuride development transdermal patch subcutaneous implant treatment parkinsons disease restless legs syndrome dyskinesias development morning glory argyreia nervosa hawaiian baby woodrose ipomoea sppmorning glory tlitliltzin badoh negro rivea corymbosa coaxihuitl ololiúqui httpsenwikipediaorgwikilisuride